An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer [2]
10.1080/02841860600762971
Saved in:
Main Authors: | Toh, C.-K., Lee, P., Chowbay, B., Goh, J.W.K., Mancer, K., Tan, P.-H. |
---|---|
Other Authors: | ZOOLOGY |
Format: | Others |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/106935 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer
by: Ho, Y.S, et al.
Published: (2020) -
Management of parapneumonic pleural effusion
by: Lim, T.K.
Published: (2016) -
Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions
by: Nyat, K.C., et al.
Published: (2016) -
Erlotinib in previously treated non-small-cell lung cancer
by: Frances A. Shepherd, et al.
Published: (2018) -
Pleural effusion in childhood falciparum malaria
by: Chukiat Sirivichayakul, et al.
Published: (2018)